Johnson & Johnson (NYSE:JNJ) has discontinued a combination therapy involving its experimental antibody therapy, nipocalimab, for rheumatoid arthritis after a failure in a mid-stage trial, which ...
Humira (adalimumab) is a biologic medication used to treat several chronic inflammatory conditions, including rheumatoid arthritis, Crohn’s disease, and plaque psoriasis. For years, it has been one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results